The American Stock Exchange (Amex) listed the common stock of Caraco Pharmaceutical Laboratories, Ltd. (Amex: CPD). Detroit-based Caraco Pharmaceutical Laboratories, Ltd., develops, manufactures and distributes generic and private-label prescription drugs to some of the nation's largest wholesalers, distributors, drugstore chains, healthcare systems and state and federal agencies.

"We are pleased to welcome Caraco Pharmaceutical Laboratories to the American Stock Exchange," said John McGonegal, vice president of the Amex Equities Group. "We plan on working with Caraco and providing them with the necessary value-added services and resources a growing company needs to succeed in today's market."

"The move to the Amex is intended to enhance share value by increasing the stock's visibility and liquidity. We expect the shares will be listed in financial publications such as the Wall Street Journal, Investor's Business Daily, Barron's and others that report share information from the Amex and the other major exchanges," said Narendra N. Borkar, Chief Executive Officer of Caraco Pharmaceutical Laboratories, Ltd. "In addition, our move to the Amex qualifies our shares to be purchased by a wider range of investors, including institutions, many of which restrict purchases to companies listed on the major exchanges," he added.